🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Philip W. Askenase

Yale University

ORCID: 0000-0001-8345-120X

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Orally Administered Exosomes Suppress Mouse Delayed-Type Hypersensitivity by Delivering miRNA-150 to Antigen-Primed Macrophage APC Targeted by Exosome-Surface Anti-Peptide Antibody Light Chains”.

Orally Administered Exosomes Suppress Mouse Delayed-Type Hypersensitivity by Delivering miRNA-150 to Antigen-Primed Macrophage APC Targeted by Exosome-Surface Anti-Peptide Antibody Light Chains

International Journal of Molecular Sciences(2020)10.3390/ijms21155540

N/A

0.533DataRank · unranked

34 citations

Krzysztof Bryniarski, Włodzimierz Ptak, Tom Groot Kormelink, Philip W. Askenase, Katarzyna Nazimek

Antibodies Enhance the Suppressive Activity of Extracellular Vesicles in Mouse Delayed-Type Hypersensitivity

Pharmaceuticals(2021)10.3390/ph14080734

N/A

0.385DataRank · unranked

12 citations

Eugenio Bustos‐Morán, Noelia Blas‐Rus, Bernadeta Nowak, Justyna Totoń‐Żurańska, Michał T. Seweryn +8 more

Extracellular Vesicle (EV) Targeted Cells Release Secondary Effector EVs: Indication of How To Account for Histocompatibility and Disease Specificity of EV Treatments

Journal of Extracellular Vesicles(2025)10.1002/jev2.70076

N/A

0.277DataRank · unranked

5 citations

Philip W. Askenase

Exosomes provide unappreciated carrier effects that assist transfers of their miRNAs to targeted cells; I. They are ‘The Elephant in the Room’

RNA Biology(2021)10.1080/15476286.2021.1885189

N/A

0DataRank · unranked

20 citations

Philip W. Askenase

Natural killer cell‐mediated contact dermatitis‐like reaction induced by treatment with TLR3 ligand poly(I:C)

Contact Dermatitis(2023)10.1111/cod.14380

N/A

0DataRank · unranked

1 citations

Paulina Kowalczyk, Philip W. Askenase, Marian Szczepanik, Monika Majewska‐Szczepanik

Extracellular vesicles as precision therapeutics for psychiatric conditions: targeting interactions among neuronal, glial, and immune networks

Frontiers in Immunology(2025)10.3389/fimmu.2025.1454306

N/A

0DataRank · unranked

5 citations

Václav Špička, James C. K. Lai, Philip W. Askenase, Wen Li, Zdeněk Kejík +4 more

Extracellular Vesicle (EV) Targeted Cells Release Secondary Effector EVs: Indication of How We Can Account for Histocompatibility and Disease Specificity of MSC EV Treatments

Preprints.org(2025)10.20944/preprints202505.0896.v1

N/A

0DataRank · unranked

0 citations

Philip W. Askenase

Orally Administered Exosomes Alleviate Mouse Contact Dermatitis through Delivering miRNA-150 to Antigen-Primed Macrophages Targeted by Exosome-Surface Antibody Light Chains

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.22.214866

N/A

0DataRank · unranked

7 citations

Krzysztof Bryniarski, Włodzimierz Ptak, Tom Groot Kormelink, Philip W. Askenase, Katarzyna Nazimek

Ancient Origin Properties of Natural Exosomes Contribute to Their Therapeutic Superiority Compared to Artificial Nanoparticles

Preprints.org(2020)10.20944/preprints202006.0200.v1

N/A

0DataRank · unranked

3 citations

Philip W. Askenase